In its recent decision, T 1635/09 (OJ EPO 542, 2011), Technical Board of Appeal 3.3.02 of the European Patent Office (EPO) has commented on the second medical use of a medicament under...

In order to harmonize and aid in the interpretation of the requirements set out in the national patent laws of the EU member states regarding the patentability of inventions in the field of biotechnology...

In its decision X ZR 68/08 – “Memantin”, dated June 9, 2011, the Federal Court of Justice in Germany heard a case concerning the use of a known medicament for treating a particular disease. In...